Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis
- PMID: 20692633
- PMCID: PMC4001925
- DOI: 10.1016/j.prrv.2010.05.003
Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis
Abstract
Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures
References
-
- Andersen DH. Cystic fibrosis of the pancreas and its relationship to celiac disease: a clinical and pathological study. Am J Dis Child. 1938;56:344.
-
- Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245(4922):1073–1080. - PubMed
-
- Lee TW. Eradication of early Pseudomonas infection in cystic fibrosis. Chron Respir Dis. 2009;6(2):99–107. - PubMed
-
- Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 1998;95(7):1005–1015. - PubMed
-
- Sagel SD, Sontag MK, Accurso FJ. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis. Pediatr Pulmonol. 2009;44(4):402–409. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
